21 ElsnerovaK.Mohelnikova-DuchonovaB.CerovskaE.EhrlichovaM.GutI.RobL.et al (2016)
GLP-1 receptor agonists available in the UK include: Semaglutide : Ozempic (for type 2 diabetes), Wegovy (for weight management), and Rybelsus (oral formulation for type 2 diabetes) Dulaglutide (Trulicity) for type 2 diabetes Liraglutide : Victoza (for type 2 diabetes), Saxenda (for weight management) Exenatide (Byetta) for type 2 diabetes Most GLP-1 receptor agonists are administered via subcutaneous injection , with dosing frequencies varying from twice daily to once weekly depending on the specific formulation
This could make it harder for the body to regulate weight
Pregnancy planning also affects durationmedication-specific washout periods apply (approximately 2 months for semaglutide, 1 month for tirzepatide/dulaglutide, and immediate discontinuation for liraglutide when pregnancy is recognized)
The case series described what happen to three female patients, ranging in ages from 27 to 46 years, who went to an oral medicine clinic in Saudi Arabia complaining about having severe dry mouths after taking semaglutide for weight loss for six to 16 weeks
Now supporting the GLP-1 era